KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Other Operating Expenses (2019 - 2025)

Aurinia Pharmaceuticals' Other Operating Expenses history spans 7 years, with the latest figure at $5.1 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 12.61% year-over-year to $5.1 million; the TTM value through Dec 2025 reached -$9.5 million, down 319.23%, while the annual FY2025 figure was -$9.5 million, 319.23% down from the prior year.
  • Other Operating Expenses reached $5.1 million in Q4 2025 per AUPH's latest filing, up from -$929000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $5.1 million in Q4 2025 to a low of -$9.2 million in Q2 2025.
  • Average Other Operating Expenses over 5 years is -$630650.0, with a median of $115000.0 recorded in 2021.
  • Peak YoY movement for Other Operating Expenses: surged 1543.28% in 2021, then crashed 3288.28% in 2025.
  • A 5-year view of Other Operating Expenses shows it stood at $285000.0 in 2021, then surged by 661.4% to $2.2 million in 2022, then crashed by 518.16% to -$9.1 million in 2023, then skyrocketed by 149.66% to $4.5 million in 2024, then rose by 12.61% to $5.1 million in 2025.
  • Per Business Quant, the three most recent readings for AUPH's Other Operating Expenses are $5.1 million (Q4 2025), -$929000.0 (Q3 2025), and -$9.2 million (Q2 2025).